Press release
ALS Treatment Market to Witness a Healthy CAGR of 19.21% by 2026 - ASURAGEN, INC., Als BioPharma LLC., CYTOKINETICS, INC., CENTOGENE AG, AcuraStem
ALS Treatment Market
Global ALS treatment Market is set to witness a healthy CAGR of 19.21% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Increasing R&D for new amyotrophic lateral sclerosis therapies and rising cases of ALS are the factor for the growth of this market.
Request a Sample Report of Global ALS treatment Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-als-treatment-market
Global ALS Treatment Market By Drug Type (Riluzole, Nuedexta, Edaravone, Others), Treatment (Chemotherapy, Stem Cell Therapy), Distribution Channel (Hospitals, Diagnostic Centers, Clinics, Retail Pharmacies), Type (Intravenous, Oral), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends & Forecast to 2026
Some of the major competitors currently working in the global ALS treatment market are Mitsubishi Tanabe Pharma Corporation, Takeda Pharmaceutical Company Limited, Sanofi, Mylan N.V., Sun Pharmaceutical Industries Ltd., ASURAGEN, INC., Als BioPharma LLC., CYTOKINETICS, INC., CENTOGENE AG, AcuraStem, Bach Pharma, Inc., AB Science, Neurimmune, Amylyx Pharmaceuticals Inc., Biogen International, MediciNova, Inc., Immunity Pharma Ltd., Biohaven Pharmaceuticals., BrainStorm Cell Limited., and others.
Market Definition:
Amyotrophic lateral sclerosis or Lou Gehrig's disease, or motor neurone disease is a degenerative disease which usually destroys the nerve cells and creates disability. They usually kill the neurons which control our voluntary muscles which are responsible for movements such as walking, chewing and talking. Riluzole, edaravone and riluzone are some of the drugs which are used for treatment of ALS. Stem cell therapy and chemotherapy are the treatments which are provided to the patient with ALS. Increasing cases of ALS worldwide is the factor fueling the growth of this market.
Market Drivers
o Rising cases of amyotrophic lateral sclerosis is driving the market
o Increasing aging population will also propel market
o Rising government concern toward the various treatment options for ALS will also drive market
o Growing focus of manufacturer on novel drug development for ALS is contributing as a factor for the growth
Market Restraints
o High price of the treatment of ALS will restrain market
o Lack of awareness about the disease among population will also hamper market
o Unavailability of effective diagnostic method will also contribute as a factor restricting the growth
For More Information on this report, Request Inquiry @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-als-treatment-market
Segmentation:
By Drug Type
o Riluzole
o Nuedexta
o Edaravone
o Others
By Treatment
o Chemotherapy
o Stem Cell Therapy
By Distribution Channel
o Hospitals
o Diagnostic Centers
o Clinics
o Retail Pharmacies
By Type
o Intravenous
o Oral
By Geography
o North America
o U.S.
o Canada
o Mexico
o Europe
o Germany
o Italy
o U.K.
o France
o Spain
o Netherlands
o Belgium
o Switzerland
o Turkey
o Russia
o Rest of Europe
o Asia-Pacific
o Japan
o China
o India
o South Korea
o Australia
o Singapore
o Malaysia
o Thailand
o Indonesia
o Philippines
o Rest of Asia-Pacific
o South America
o Brazil
o Rest of South America
o Middle East and Africa
o South Africa
o Rest of Middle East and Africa
Key Developments in the Market:
o In May 2019, The ALS Therapy Development Institute announced the launch of their new campaign so that they create more discussion about the progressive neurological disease. They are encouraging advocates and other caretaker to use #AskMeAboutALS so that they can increase the awareness about the disease and get more therapies and cure. The main aim of the campaign is to create more information among population about the ALS.
o In November 2018, Biohaven announced that they have received FDA acceptance of 505(b)(2) NDA filing for BHV-0223 which is designed for the treatment of amyotrophic lateral sclerosis (ALS). This is a lower dose formulation which when kept under tongue has the ability to get dissolved in seconds. This new treatment is very beneficial for the people who are living with ALS.
Competitive Analysis:
Global ALS treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of ALS treatment market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Reasons to Purchase this Report
o Current and future of global ALS treatment market outlook in the developed and emerging markets
o The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
o Regions/Countries that are expected to witness the fastest growth rates during the forecast period
o The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
o All segmentation provided above in this report is represented at country level
o All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)
Get Detailed Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-als-treatment-market
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com
About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release ALS Treatment Market to Witness a Healthy CAGR of 19.21% by 2026 - ASURAGEN, INC., Als BioPharma LLC., CYTOKINETICS, INC., CENTOGENE AG, AcuraStem here
News-ID: 1907273 • Views: …
More Releases from Data Bridge Market Research
Sparkling Juices Market to Observe Prominent CAGR of 8.5% by 2030, Size, Share, …
Data Bridge Market Research analyses the market is expected to reach USD 181.69 million by 2030 from 94.60 million in 2022 growing at a CAGR of 8.5 % in the sparkling Juices market.
Market Definition:
Sparkling juice is a non-alcoholic beverage made by carbonating fruit juice. It typically contains real fruit juice, carbonated water, and sweeteners. The carbonation gives it a fizzy, effervescent quality, similar to soda or champagne, without the alcohol.…
Cistanche Deserticola Market to Observe Prominent CAGR of 5.6% by 2031, Size, Sh …
Data Bridge Market Research analyzes that the cistanche deserticola market is expected to undergo a CAGR of 5.6% during the forecast period. "Knowledge-Based" dominates the type segment of the Cistanche deserticola market owing to the growing demand for better methods for treatment in patients.
Market Definition:
Cistanche deserticola is one of the endangered herbal species founded in arid and semi-arid conditions. This species is extensively used for treatment of several kinds of…
Breast Prosthesis Market to Observe Prominent CAGR of 8.3% by 2031, Size, Share, …
Data Bridge Market Research analyzes that the global breast prosthesis market is expected to reach USD 594,575.57 thousand by 2031 from USD 319,959.41 thousand million in 2023, growing at a CAGR of 8.3% in the forecast period of 2024 to 2031.
Market Definition:
A breast prosthesis is an artificial breast form designed to replace all or part of a natural breast that has been removed due to mastectomy, lumpectomy, or other medical…
Exploring the Aesthetic Devices Market: An In-Depth Analysis 2029
The aesthetic devices market has evolved significantly, driven by advancements in technology and growing consumer demand for non-invasive cosmetic procedures. Aesthetic devices encompass a range of equipment used for enhancing physical appearance, including lasers, radiofrequency devices, ultrasound machines, and more. These devices cater to various cosmetic needs, from skin rejuvenation to body contouring. This post provides a comprehensive overview of the aesthetic devices market, detailing its scope, exploring current market…
More Releases for ALS
ALS Contract Services joins J. Mallinson (Ormskirk) Ltd
J. Mallinson is extremely delighted to announce that following a period of extensive searching for a specialist strategic business partner, they have purchased ALS Contract Services from Agrovista, a leading supplier of agronomy advice, seed, crop protection products and precision farming services for an undisclosed fee. The acquisition will protect the long-term future of ALS and the business will provide a workforce of 35 in construction and sports pitch management…
ALS Contract Services joins J. Mallinson (Ormskirk) Ltd
J. Mallinson is extremely delighted to announce that following a period of extensive searching for a specialist strategic business partner, they have purchased ALS Contract Services from Agrovista, a leading supplier of agronomy advice, seed, crop protection products and precision farming services for an undisclosed fee. The acquisition will protect the long-term future of ALS and the business will provide a workforce of 35 in construction and sports pitch management…
Food Certification Market Future Growth Outlook | Intertek, BV, ALS
Latest survey on Food Certification Market is conducted to provide hidden gems performance analysis to better demonstrate competitive environment of Food Certification. The study is a mix of quantitative market stats and qualitative analytical information to uncover market size revenue breakdown by key business segments and end use applications. The report bridges the historical data from 2015 to 2020 and forecasted till 2026*, the outbreak of latest scenario in Food…
Amyotrophic Lateral Sclerosis (ALS) Treatment Market : Trends And Growth
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease and motor neuron disease (MND), is a neurodegenerative disease, affecting nerve cells in the brain and spinal cord that controls voluntary muscles. The disease is progressive in nature, meaning it gets worse over time.
According to a study published in Centers for Disease Control and Prevention, in 2016, around 14,713 people were diagnosed with ALS in the U.S. and prevalence rate…
Global Palladium Electrode Market 2018 - Metrohm, Murata, Kemet, ALS Co
The Global Palladium Electrode Market 2018 research report presents an in-depth research of the Global Palladium Electrode Sales Market alongside the Palladium Electrode market size and growth rate, classification of the Palladium Electrode industry based on products, and leading Palladium Electrode industry players as well. The Palladium Electrode industry report summarizes the global market insights that are key drivers for growth of the Palladium Electrode sales market over the forecast…
Page Director ALS Now Compatible with InDesign CS5, QuarkXPress 8.5
Jenkintown, PA (December 20, 2010) — Managing Editor Inc. (MEI), an Adobe premier development partner and a leading provider of software solutions for the publishing industry, today announced that Page Director® Ad Layout System 5.6.1, ALS for Magazines 5.6.1 and AdForce 5.6.1 are now available. MEI’s flagship product and its related technologies have been upgraded for compatibility with the latest pagination software from Adobe® and Quark®.
ALS 5.6.1 comes standard with…
